Celecoxib.

Journal of the Royal Society of Medicine ·Vol. 99 ·No. 7 ·2006-07-00 ·Pages 336

Cheung R, Lowry S

Abstract

暂无摘要

MeSH Terms

Anti-Inflammatory Agents, Non-Steroidal/adverse effects Cardiovascular Diseases/chemically induced Celecoxib Cyclooxygenase 2 Inhibitors/adverse effects Humans Meta-Analysis as Topic Pyrazoles/adverse effects Sulfonamides/adverse effects

Chemicals

Anti-Inflammatory Agents, Non-Steroidal Cyclooxygenase 2 Inhibitors Pyrazoles Sulfonamides Celecoxib

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Cheung Raymond

Lowry Simon

References (3)

3 references, click to expand

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.
Am J Cardiol. 2002 Feb 15;89(4):425-30 PMID: 11835924
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.
Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):266-74 PMID: 16611201
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.
J R Soc Med. 2006 Mar;99(3):132-40 PMID: 16508052

Article Info

Journal

Journal of the Royal Society of Medicine

Abbr.

J R Soc Med

ISSN

0141-0768

DOI

10.1258/jrsm.99.7.336

Published

2006-07-00

Pages

336

Language

English

Region

England

NLM ID

7802879

PMCID

PMC1484551

Subset

Corrections

CommentOn

PMID: 16508052

External Links

PubMed source DOI: 10.1258/jrsm.99.7.336 PMC Full Text View journal details

Analysis Services

Celecoxib.

Contact

WeChat Official Account